AI assistant
Editas Medicine, Inc. — Director's Dealing 2016
Feb 2, 2016
33260_dirs_2016-02-02_72dd37fd-ea41-4256-8365-ab1b1573e427.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2016-02-02
Reporting Person: Cole Douglas G. (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 0 | Direct |
Footnotes
F1: Mr. Cole does not own shares in his individual capacity. He is a non-controlling member of Flagship Ventures Fund IV General Partner LLC, the general partner of Flagship Ventures Fund IV, L.P. ("Flagship IV") and Flagship Ventures Fund IV-Rx, L.P. ("Flagship IV-Rx"). Flagship IV and Flagship IV-Rx are each a reporting person and each has filed a Form 3 reporting its respective ownership. Mr. Cole disclaims beneficial ownership of the shares owned by Flagship IV and Flagship IV-Rx, except to the extent of his pecuniary interest therein.